 Glaukos Corporation NYSE: GKOS, an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release second quarter 2020 financial results after the market close on Thursday, August 6, 2020. The companys management will discuss the results during a conference call and simultaneous webcast at 1:30 p.m. PDT 4:30 p.m. EDT on August 6, 2020. 